ヘルスケアにおけるブロックチェーン市場：業界動向と世界の予測 - ブロックチェーンタイプ別、エンドユーザータイプ別、主要地域別

世界のヘルスケアにおけるブロックチェーン市場：概要

世界のヘルスケアにおけるブロックチェーンの市場規模は、2035年までの予測期間中に22.8%のCAGRで拡大し、現在の6,700万米ドルから2035年までに6億4,100万米ドルに成長すると予測されています。

市場セグメンテーションでは、市場規模および機会分析を以下のパラメータで区分しています：

ブロックチェーンタイプ

• パブリック・ブロックチェーン
• プライベート・ブロックチェーン
• ハイブリッド・ブロックチェーン
• その他

エンドユーザータイプ

• 病院
• 製薬業界
• 研究機関
• 学術機関

主要地域

• 北米
• 欧州
• アジア太平洋
• その他の地域

世界のヘルスケアにおけるブロックチェーン市場：成長と動向

近年、ブロックチェーンは、銀行、サプライチェーン管理、ヘルスケアなどの様々な業界において、分散型の金銭取引やデータ交換のための汎用性の高いツールであることが証明されたため、業界関係者だけでなく、研究者からも大きな関心を集めています。ヘルスケアにおけるいくつかの利害関係者は、患者記録の管理、治験のための患者募集、サプライチェーンにおける透明性とトレーサビリティの提供など、さまざまな業務にブロックチェーンを採用しています。さらに、医薬品のライフサイクル管理を大幅に改善する手法として、効果的かつ潜在的に利用することができます。ヘルスケアにおけるブロックチェーンは徐々に、大きな利点を解き放つことで、前例のない機会を開示してきました。

ブロックチェーン技術に対する利害関係者の関心は高まっていますが、スケーラビリティの問題、セキュリティの欠如、サイバー攻撃など、いくつかの課題を抱えています。前述の課題に対処するため、組織は透明性とプライバシーを確立し、機密性の高い患者データを隠す一方で、必要な場合にのみアクセスを許可しています。さらに、先進的なプラットフォームを開発しようとする業界参入企業の継続的な努力に後押しされ、世界のブロックチェーン市場は予測される将来において大きなペースで成長すると予想されます。

世界のヘルスケアにおけるブロックチェーン市場：主要インサイト

当レポートでは、世界のヘルスケアにおけるブロックチェーン市場の現状を掘り下げ、業界内の潜在的な成長機会を特定しています。当レポートの主な調査結果は以下の通りです：

• 現在、50社以上の企業が幅広い医薬品開発においてブロックチェーンプラットフォームソリューションを提供していると主張しています。
• 現在の市場情勢は、様々な医薬品開発向けにブロックチェーン技術を業界に提供している利害関係者を特徴としており、これらの技術プラットフォームの大半は臨床試験管理に利用されています。

• 利害関係者は競争優位性を築くために、既存の機能を強化し、高度な機能を備えた独自のブロックチェーンプラットフォームのアップグレードに努めています。
• 製薬業界におけるブロックチェーン技術の利用に焦点を当てた論文の約37%は最近発表されたもので、調査別実質的な取り組みが浮き彫りになっています。
• ここ数年、ブロックチェーンに関連する論文数は大幅に増加しており、最近では130本の論文が発表されています。
• この分野の出版物の大部分（～60％）は、医薬品サプライチェーンや臨床試験管理におけるブロックチェーンの利用評価に焦点を当てた調査論文です。
• 利害関係者の関心が高まっていることは、最近のパートナーシップ活動の活発化からもうかがえます。これまでのところ、取引の~60%は独自のブロックチェーンプラットフォームの活用と統合に焦点を当てています。
• 過去数年間、この分野でのパートナーシップ活動はCAGR 73%以上で増加しており、取引の大半はプラットフォーム利用契約でした。
• 大陸間取引の大部分は北米と欧州を拠点とする参入企業間で締結されており、これらのパートナーシップの25％は2022年に締結されています。
• 臨床研究、特に創薬と臨床試験におけるブロックチェーンの需要の増加は、この分野の参入企業に有利なビジネスチャンスをもたらすと予想されます。
• 同市場は今後10年間で年率22%の成長を遂げると予想され、その機会は様々な種類のブロックチェーン、エンドユーザーの種類、主要な地理的地域にうまく分散されると思われます。

世界のヘルスケアにおけるブロックチェーン市場：主要セグメント

ブロックチェーンタイプ別では、市場はパブリックブロックチェーン、プライベートブロックチェーン、ハイブリッドブロックチェーン、その他に区分されます。現在、プライベートブロックチェーンセグメントが世界のヘルスケアにおけるブロックチェーン市場で最大（～40％）のシェアを占めています。さらに、パブリックブロックチェーンセグメントは、他のセグメントと比較して速いペースで成長する可能性が高いです。

エンドユーザータイプ別では、市場は病院、製薬業界、研究機関、学術機関に区分されます。現在、病院セグメントがヘルスケア市場におけるブロックチェーンで最も高い割合（～40％）を占めています。さらに、製薬産業セグメントは比較的高いCAGRで成長する可能性が高いです。

主要地域別に見ると、市場は北米、欧州、アジア太平洋、その他の地域に区分されます。現在、アジア太平洋地域（40％以上）がヘルスケアにおけるブロックチェーン市場を独占し、最大の収益シェアを占めています。しかし、世界のその他の地域の市場はより高いCAGRで成長すると予想されています。

ヘルスケアにおけるブロックチェーン市場の参入企業例

• Alten Calsoft Labs
• ConsenSys
• Humanscape
• Hyperledger Foundation
• IBM
• Infosys
• Innoplexus
• Medsphere
• Solulab
• Stratumn
• Tech Mahindra

当レポートでは、世界のヘルスケアにおけるブロックチェーン市場について調査し、市場の概要とともに、ブロックチェーンタイプ別、エンドユーザータイプ別動向、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 イントロダクション

• 章の概要
• ブロックチェーン技術の概要
• ブロックチェーンタイプ
• 様々な業界におけるブロックチェーンの応用
• 創薬と臨床試験におけるブロックチェーンの応用
• ブロックチェーンの利点と限界
• 将来の展望

第4章 市場概要

• 章の概要
• ブロックチェーン技術プロバイダーのリスト

第5章 企業競争力分析

• 章の概要
• 前提/主要パラメータ
• 調査手法
• 企業競争力分析：北米に拠点を置くブロックチェーン技術プロバイダー（ピアグループI）
• 企業競争力分析：欧州に拠点を置くブロックチェーン技術プロバイダー（ピアグループII）
• 企業競争力分析：アジア太平洋およびその他の地域に拠点を置くブロックチェーン技術プロバイダー（ピアグループIII）

第6章 企業プロファイル

• 章の概要
• Alten Calsoft Labs
• ConsenSys
• IBM
• Stratumn
• Infosys
• Tech Mahindra
• Humanscape
• Hyperledger Foundation
• Innoplexus
• Medsphere
• Solulab

第7章 パートナーシップとコラボレーション

• 章の概要
• パートナーシップモデル
• 創薬と臨床試験におけるブロックチェーン：最近のパートナーシップとコラボレーション

第8章 出版物の分析

第9章 SWOT分析

• 章の概要
• 創薬と臨床試験におけるブロックチェーン：SWOT分析
• SWOT要因の比較

第10章 ケーススタディ：ヘルスケアおよびその他の業界におけるブロックチェーンの応用

• 章の概要
• 様々な業界におけるブロックチェーンの応用
  • ヘルスケアにおけるブロックチェーン
  • 銀行・金融業界におけるブロックチェーン
  • 自動車業界におけるブロックチェーン
  • 教育におけるブロックチェーン
  • 通信業界におけるブロックチェーン
  • 交通におけるブロックチェーン
  • 旅行業界におけるブロックチェーン

第11章 市場予測と機会分析

• 章の概要
• 主要な前提と調査手法
• 2035年までの創薬・臨床試験市場におけるブロックチェーン
• 創薬・臨床試験市場におけるブロックチェーン：ブロックチェーンタイプ別
• 創薬・臨床試験市場におけるブロックチェーン：エンドユーザー別
• 創薬・臨床試験市場におけるブロックチェーン：主要地域別

第12章 結論

第13章 エグゼクティブ洞察

第14章 付録1：表形式データ

第15章 付録2：企業・団体一覧

List of Tables

• Table 4.1 List of Blockchain Technology Providers
• Table 4.2 Blockchain Technology Providers: Information on Type of Blockchain(s)
• Table 4.3 Blockchain Technology Providers: Information on Type of Drug Development Application(s)
• Table 4.4 Blockchain Technology Providers: Information on Application(s) within Clinical Trial Management
• Table 4.5 Blockchain Technology Providers: Information on Type of End-User(s)
• Table 6.1 Blockchain in Drug Discovery and Clinical Trials: List of Companies Profiled
• Table 6.2 Alten Calsoft Labs: Key Highlights
• Table 6.3 Alten Calsoft Labs: Recent Developments and Future Outlook
• Table 6.4 ConsenSys: Key Highlights
• Table 6.5 ConsenSys: Recent Developments and Future Outlook
• Table 6.6 IBM: Key Highlights
• Table 6.7 IBM: Recent Developments and Future Outlook
• Table 6.8 Stratumn: Key Highlights
• Table 6.9 Infosys: Key Highlights
• Table 6.10 Infosys: Recent Developments and Future Outlook
• Table 6.11 Tech mahindra: Key Highlights
• Table 6.12 Tech Mahindra: Recent Developments and Future Outlook
• Table 6.13 Blockchain in Drug Discovery and Clinical Trials: List of Companies Profiled
• Table 6.14 Humanscape: Key Highlights
• Table 6.15 Humanscape: Application Areas of Proprietary Platform
• Table 6.16 Humanscape: Recent Developments and Future Outlook
• Table 6.17 Hyperledger Foundation: Key Highlights
• Table 6.18 Hyperledger Foundation: Application Areas of Proprietary Platform
• Table 6.19 Hyperledger Foundation: Recent Developments and Future Outlook
• Table 6.20 Innoplexus: Key Highlights
• Table 6.21 Innoplexus: Application Areas of Proprietary Platform
• Table 6.22 Innoplexus: Recent Developments and Future Outlook
• Table 6.23 Medsphere: Key Highlights
• Table 6.24 Medsphere: Application Areas of Proprietary Platform
• Table 6.25 Medsphere: Recent Developments and Future Outlook
• Table 6.26 Solulab: Key Highlights
• Table 6.27 Solulab: Application Areas of Proprietary Platform
• Table 6.28 Solulab: Recent Developments and Future Outlook
• Table 7.1 Blockchain in Drug Discovery and Clinical Trials: List of Partnerships and Collaborations, Since 2017
• Table 10.1 Blockchain Technology in Education: Use Cases
• Table 14.1 Blockchain Technology Providers: Distribution by Year of Establishment
• Table 14.2 Blockchain Technology Providers: Distribution by Company Size
• Table 14.3 Blockchain Technology Providers: Distribution by Region of Headquarters
• Table 14.4 Blockchain Technology Providers: Distribution by Location of Headquarters
• Table 14.5 Blockchain Technology Providers: Distribution by Year of Establishment, Company Size, and Region of Headquarters
• Table 14.6 Blockchain Technology Providers: Distribution by Type of Blockchain(s)
• Table 14.7 Blockchain Technology Providers: Distribution by Type of Drug Development Application(s)
• Table 14.8 Blockchain Technology Providers: Distribution by Application(s) within Clinical Trial Management
• Table 14.9 Blockchain Technology Providers: Distribution by Type of End-User(s)
• Table 14.10 Blockchain Technology Providers: Distribution by Type of Blockchain and Type of End-User(s)
• Table 14.11 Blockchain Technology Providers: Distribution by Type of Blockchain and Type of Drug Development Application(s)
• Table 14.12 Alten Calsoft Labs: Annual Revenues, Since 2018 (EUR Billion)
• Table 14.13 IBM: Annual Revenues, Since 2018 (USD Billion)
• Table 14.14 Infosys: Annual Revenues, Since 2018 (USD Billion)
• Table 14.15 Tech Mahindra: Annual Revenues, Since 2018 (USD Billion)
• Table 14.16 Partnerships and Collaborations: Distribution by Year of Partnership, Since 2017
• Table 14.17 Partnerships and Collaborations: Distribution by Type of Partnership
• Table 14.18 Partnerships and Collaborations: Distribution by Year and Type of Partnership, Since 2017
• Table 14.19 Partnerships and Collaborations: Distribution by Company Size and Type of Partnership
• Table 14.20 Most Active Players: Distribution by Number of Partnerships
• Table 14.21 Most Active Players: Distribution by Type of Partnerships
• Table 14.22 Partnerships and Collaborations: Distribution by Type of Pharmaceutical Applications
• Table 14.23 Partnerships and Collaborations: Distribution by Type of Partner
• Table 14.24 Partnerships and Collaborations: Local and International Agreements
• Table 14.25 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
• Table 14.26 Publication Analysis: Cumulative Year-Wise Trend, Since 2016
• Table 14.27 Publication Analysis: Distribution by Type of Article
• Table 14.28 Popular Journals: Distribution by Number of Publications
• Table 14.29 Popular Publishers: Distribution by Number of Publications
• Table 14.30 Popular Copyright Holders: Distribution by Number of Publications
• Table 14.31 Publication Analysis: Distribution by Impact Factor
• Table 14.32 Popular Journals: Distribution by Journal Impact Factor
• Table 14.33 Blockchain in Drug Discovery and Clinical Trials Market Till 2035, Conservative, Base, and Optimistic Scenarios, Till 2035 (USD Million)
• Table 14.34 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of Blockchain
• Table 14.35 Blockchain in Drug Discovery and Clinical Trials Market for Public Blockchain, Till 2035: Conservative, Base, and Optimistic Scenarios (USD Million)
• Table 14.36 Blockchain in Drug Discovery and Clinical Trials Market for Private Blockchain, Till 2035: Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 14.37 Blockchain in Drug Discovery and Clinical Trials Market for Hybrid Blockchain, Till 2035: Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 14.38 Blockchain in Drug Discovery and Clinical Trials Market for Other Blockchains, Till 2035: Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 14.39 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of End-User
• Table 14.40 Blockchain in Drug Discovery and Clinical Trials Market for Hospitals, Till 2035: Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 14.41 Blockchain in Drug Discovery and Clinical Trials Market for Pharmaceutical Industry, Till 2035: Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 14.42 Blockchain in Drug Discovery and Clinical Trials Market for Research Institutes, Till 2035: Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 14.43 Blockchain in Drug Discovery and Clinical Trials Market for Academic Institutes, Till 2035: Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 14.44 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Key Geographical Regions
• Table 14.45 Blockchain in Drug Discovery and Clinical Trials Market in North America, Till 2035: Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 14.46 Blockchain in Drug Discovery and Clinical Trials Market in Europe, Till 2035: Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 14.47 Blockchain in Drug Discovery and Clinical Trials Market in Asia- Pacific, Till 2035: Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 14.48 Blockchain in Drug Discovery and Clinical Trials Market in Rest of the World, Till 2035: Conservative, Base and Optimistic Scenarios, (USD Million)

List of Figures

• Figure 2.1 Executive Summary: Overall Market Landscape
• Figure 2.2 Executive Summary: Partnerships and Collaborations
• Figure 2.3 Executive Summary: Publication Analysis
• Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
• Figure 3.1 Historical Evolution of Blockchain Technology
• Figure 3.2 Types of Blockchain
• Figure 3.3 Applications of Blockchain Across Various Industries
• Figure 3.4 Advantages and Limitations of Blockchain
• Figure 4.1 Blockchain Technology Providers: Distribution by Year of Establishment
• Figure 4.2 Blockchain Technology Providers: Distribution by Company Size
• Figure 4.3 Blockchain Technology Providers: Distribution by Region of Headquarters
• Figure 4.4 Blockchain Technology Providers: Distribution by Location of Headquarters
• Figure 4.5 Blockchain Technology Providers: Distribution Year of Establishment, Company Size, and Region of Headquarters
• Figure 4.6 Blockchain Technology Providers: Distribution by Type of Blockchain(s)
• Figure 4.7 Blockchain Technology Providers: Distribution by Type of Drug Development Application(s)
• Figure 4.8 Blockchain Technology Providers: Distribution by Application(s) within Clinical Trial Management
• Figure 4.9 Blockchain Technology Providers: Distribution by Type of End-User(s)
• Figure 4.10 Blockchain Technology Providers: Distribution by Type of Blockchain and Type of End-User(s)
• Figure 4.11 Blockchain Technology Providers: Distribution by Type of Blockchain and Type of Drug Development Application(s)
• Figure 5.1 Company Competitiveness Analysis: Blockchain Technology Providers based in North America (Peer Group I)
• Figure 5.2 Company Competitiveness Analysis: Blockchain Technology Providers based in Europe (Peer Group II)
• Figure 5.3 Company Competitiveness Analysis: Blockchain Technology Providers based in Asia Pacific and RoW (Peer Group III)
• Figure 6.1 Alten Calsoft Labs: Annual Revenues, Since 2018 (EUR Billion)
• Figure 6.2 Alten Calsoft Labs: Application Areas of Proprietary Platform
• Figure 6.3 ConsenSys: Application Areas of Proprietary Platform
• Figure 6.4 IBM: Annual Revenues, Since 2018 (USD Billion)
• Figure 6.5 IBM: Application Areas of Proprietary Platform
• Figure 6.6 Stratumn: Application Areas of Proprietary Platform
• Figure 6.7 Infosys: Annual Revenues, Since 2018 (USD Billion)
• Figure 6.8 Infosys: Application Areas of Proprietary Platform
• Figure 6.9 Tech Mahindra: Annual Revenues, Since 2018 (USD Billion)
• Figure 6.10 Tech Mahindra: Application Areas of Proprietary Platform
• Figure 7.1 Partnerships and Collaborations: Distribution by Year of Partnership, Since 2017
• Figure 7.2 Partnerships and Collaborations: Distribution by Type of Partnership
• Figure 7.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
• Figure 7.4 Partnerships and Collaborations: Distribution by Company Size and Type of Partnership
• Figure 7.5 Most Active Partners: Distribution by Number of Partnerships
• Figure 7.6 Most Active Players: Distribution by Type of Partnership
• Figure 7.7 Partnerships and Collaborations: Distribution by Type of Pharmaceutical Applications
• Figure 7.8 Partnerships and Collaborations: Distribution by Type of Partner
• Figure 7.9 Partnerships and Collaborations: Local and International Agreements
• Figure 7.10 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
• Figure 8.1 Publication Analysis: Cumulative Year-wise Trend, Since 2016
• Figure 8.2 Publication Analysis: Distribution by Type of Article
• Figure 8.3 Popular Journals: Distribution by Number of Publications
• Figure 8.4 Popular Publishers: Distribution by Number of Publications
• Figure 8.5 Popular Copyright Holders: Distribution by Number of Publications
• Figure 8.6 Word Cloud: Key Focus Areas
• Figure 8.7 Publication Analysis: Distribution by Impact Factor
• Figure 8.8 Popular Journals: Distribution by Journal Impact Factor
• Figure 9.1 Blockchain Technology in Pharmaceutical Industry: SWOT Analysis
• Figure 9.2 SWOT Factors: Harvey Ball Analysis
• Figure 10.1 Key Applications of Blockchain Across Various Industries
• Figure 11.1 Blockchain in Drug Discovery and Clinical Trials Market, Till 2035 (USD Million)
• Figure 11.2 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of Blockchain (USD Million)
• Figure 11.3 Blockchain in Drug Discovery and Clinical Trials Market for Public Blockchain, Till 2035 (USD Million)
• Figure 11.4 Blockchain in Drug Discovery and Clinical Trials Market for Private Blockchain, Till 2035 USD Million)
• Figure 11.5 Blockchain in Drug Discovery and Clinical Trials Market for Hybrid Blockchain, Till 2035 USD Million)
• Figure 11.6 Blockchain in Drug Discovery and Clinical Trials Market for Other Blockchains, Till 2035 (USD Million)
• Figure 11.7 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of End-User (USD Million)
• Figure 11.8 Blockchain in Drug Discovery and Clinical Trials Market for Hospitals, Till 2035 (USD Million)
• Figure 11.9 Blockchain in Drug Discovery and Clinical Trials Market for Pharmaceutical Industry, 2023- 2035 (USD Million)
• Figure 11.10 Blockchain in Drug Discovery and Clinical Trials Market for Research Institutes, Till 2035 (USD Million)
• Figure 11.11 Blockchain in Drug Discovery and Clinical Trials Market for Academic Institutes, Till 2035 (USD Million)
• Figure 11.12 Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Key Geographical Regions (USD Million)
• Figure 11.13 Blockchain in Drug Discovery and Clinical Trials Market in North America, Till 2035 (USD Million)
• Figure 11.14 Blockchain in Drug Discovery and Clinical Trials Market in Europe, Till 2035 (USD Million)
• Figure 11.15 Blockchain in Drug Discovery and Clinical Trials Market in Asia- Pacific, Till 2035 (USD Million)
• Figure 11.16 Blockchain in Drug Discovery and Clinical Trials Market in Rest of the World, Till 2035 (USD Million)
• Figure 12.1 Concluding Remarks: Blockchain Technology Providers Market Landscape
• Figure 12.2 Concluding Remarks: Partnerships and Collaborations
• Figure 12.3 Concluding Remarks: Publication Analysis
• Figure 12.4 Concluding Remarks: SWOT Analysis
• Figure 12.4 Concluding Remarks: Market Forecast and Opportunity Analysis

GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET: OVERVIEW

As per Roots Analysis, the global blockchain in healthcare market is estimated to grow from USD 67 million in the current year to USD 641 million by 2035, at a CAGR of 22.8% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Blockchain

• Public Blockchain
• Private Blockchain
• Hybrid Blockchain
• Other Blockchains

Type of End User

• Hospitals
• Pharmaceutical Industry
• Research Institutes
• Academic Institutes

Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• Rest of the World

GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET: GROWTH AND TRENDS

In recent years, blockchain has garnered significant interest from researchers, as well as industry players, as it has proven to be a versatile tool for decentralized monetary transactions and data exchange in various industries, such as banking, supply chain management and healthcare. Several stakeholders in healthcare have adopted blockchain for various operations, such as in maintaining patient records, in recruiting patients for trials and providing transparency and traceability during the supply chain. Moreover, it can effectively and potentially be used as a method to significantly improve the drug life cycle management. Gradually, blockchain in healthcare has disclosed unprecedented opportunities by unlocking significant advantages.

Despite the growing interest of stakeholders in blockchain technology, it is associated with several challenges, including scalability issues, lack of security and cyber-attacks. In order to deal with the aforementioned challenges, organizations have established transparency and privacy to conceal sensitive patient data while allowing access, only when required. Further, driven by the continuous efforts of industry players to develop advanced platforms, we anticipate that the global blockchain market is likely to grow at a significant pace in the foreseen future

GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET: KEY INSIGHTS

The report delves into the current state of global blockchain in the healthcare market and identifies potential growth opportunities within industry. Some key findings from the report include:

• Presently, more than 50 players claim to provide blockchain platform solutions across a wide range of drug development applications.
• The current market landscape features stakeholders offering blockchain technology to industries for various drug development applications; majority of these technology platforms are being used for clinical trial management.

• In pursuit of building a competitive edge, stakeholders are striving to enhance their existing capabilities and upgrade their proprietary blockchain platforms with advanced features.
• Around 37% of the articles focused on the use of blockchain technology in the pharmaceutical industry have been published recently, highlighting the substantial efforts undertaken by researchers.
• Over the years, there has been a significant increase in the number of publications related to blockchain; 130 articles have been published recently.
• Majority (~60%) of the publications in this domain are research articles focused on evaluating the use of blockchain in drug supply chain and clinical trial management.
• The growing interest of stakeholders is also prevalent from the recent rise in partnership activity; ~60% of the deals, so far, have been focused on utilization and integration of proprietary blockchain platforms.
• In the past few years, the partnership activity in this domain has increased at a CAGR of over 73%; majority of the deals were platform utilization agreements.
• Majority of the intercontinental deals have been inked between players based in North America and Europe; 25% of these partnerships have been signed in 2022.
• The increasing demand for blockchain in clinical research, especially for drug discovery and clinical trials, is anticipated to create lucrative business opportunities for players within this field.
• We expect the market to witness an annualized growth of 22% in the coming decade; the opportunity is likely to be well distributed across various types of blockchain, types of end-users and key geographical regions.

GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET: KEY SEGMENTS

Private blockchain Segment Occupies the Largest Share of the Blockchain in Healthcare Market

Based on the type of blockchain, the market is segmented into public blockchain, private blockchain, hybrid blockchain, and other blockchains. At present, the private blockchain segment holds the maximum (~40%) share of the global blockchain in the healthcare market. Additionally, the public blockchain segment is likely to grow at a faster pace compared to the other segments.

By Type of End User, Pharmaceutical Industry Segment is the Fastest Growing Segment of the Global Blockchain in Healthcare Market

Based on the type of end user, the market is segmented into hospitals, pharmaceutical industry, research institutes and academic institutes. Currently, hospitals segment captures the highest proportion (~40%) of the blockchain in the healthcare market. Further, the pharmaceutical industry segment is likely to grow at a relatively higher CAGR.

Asia-Pacific Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Currently, Asia-Pacific (>40%) dominates the blockchain in healthcare market and accounts for the largest revenue share. However, the market in the rest of the world is expected to grow at a higher CAGR.

Example Players in the Blockchain in Healthcare Market

• Alten Calsoft Labs
• ConsenSys
• Humanscape
• Hyperledger Foundation
• IBM
• Infosys
• Innoplexus
• Medsphere
• Solulab
• Stratumn
• Tech Mahindra

GLOBAL BLOCKCHAIN IN HEALTHCARE MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global blockchain in healthcare market, focusing on key market segments, including [A] type of blockchain, [B] type of end user and [C] key geographical regions.
• Market Landscape: A comprehensive evaluation of healthcare companies using blockchain technology for drug discovery and clinical trials, considering various parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of blockchains, [E] type of drug development applications, [F] applications within clinical trial management and [G] type of end users.
• Company Competitiveness Analysis: A comprehensive company competitive analysis of blockchain technology providers, examining factors, such as [A] supplier strength, [B] portfolio diversity and [C] portfolio strength.
• Company Profiles: In-depth profiles companies providing blockchain platforms for drug discovery applications, focusing on [A] company overview, [B] financial information (if available), [C] details on application areas of proprietary platform, and [D] recent developments and an informed future outlook.
• Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the blockchain in healthcare market, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] type of pharmaceutical applications, [E] most active players (in terms of the number of partnerships signed) and [F] geography.
• Publication Analysis: An insightful analysis of more than 500 peer-reviewed scientific articles focused on blockchain in the pharmaceutical industry, based on various relevant parameters, such as [A] year of publication, [B] type of publication, [C] popular publishers, [D] popular copyright holders and [E] keywords.
• SWOT Analysis: An analysis of industry affiliated trends, opportunities and challenges, which are likely to impact the evolution of blockchain in healthcare market; it includes a Harvey ball analysis, assessing the relative impact of each SWOT parameter on industry dynamics.
• Case Study: A detailed discussion highlighting the applications of blockchain across various industries, such as [A] healthcare, [B] banking and financial, [C] automotive, [D] education, [E] telecom, [F] transportation and [G] travel industries.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Research Methodology
  • 1.2.1. Research Assumptions
  • 1.2.2. Project Methodology
  • 1.2.3. Forecast Methodology
  • 1.2.4. Robust Quality Control
  • 1.2.5. Key Considerations
    • 1.2.5.1. Demographics
    • 1.2.5.2. Economic Factors
    • 1.2.5.3. Government Regulations
    • 1.2.5.4. Supply Chain
    • 1.2.5.5. COVID Impact / Related Factors
    • 1.2.5.6. Market Access
    • 1.2.5.7. Healthcare Policies
    • 1.2.5.8. Industry Consolidation
• 1.3 Key Questions Answered
• 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

• 2.1. Chapter Overview

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Overview of Blockchain Technology
  • 3.2.1. Ethereum vs Hyperledger Fabric
• 3.3. Types of Blockchain
  • 3.3.1. Permissionless or Public Blockchain
  • 3.3.2. Permission or Private Blockchain
  • 3.3.3. Federated or Consortium Blockchain
• 3.4. Applications of Blockchain Across Various Industries
• 3.5. Applications of Blockchain in Drug Discovery and Clinical Trials
• 3.6. Advantages and Limitations of Blockchain
• 3.7. Future Perspectives

4. MARKET OVERVIEW

• 4.1. Chapter Overview
• 4.2. List of Blockchain Technology Providers
  • 4.2.1. Analysis by Year of Establishment
  • 4.2.2. Analysis by Company Size
  • 4.2.3. Analysis by Region of Headquarters
  • 4.2.4. Analysis by Location of Headquarters
  • 4.2.5. Analysis by Year of Establishment, Company Size, and Region of Headquarters
  • 4.2.6. Analysis by Type of Blockchain(s)
  • 4.2.7. Analysis by Type of Drug Development Application(s)
  • 4.2.8. Analysis by Application(s) within Clinical Trial Management
  • 4.2.9. Analysis by Type of End-User(s)
  • 4.2.10. Analysis by Type of Blockchain and Type of End-User(s)
  • 4.2.11. Analysis by Type of Blockchain and Type of Drug Development Application(s)

5. COMPANY COMPETITIVENESS ANALYSIS

• 5.1. Chapter Overview
• 5.2. Assumptions / Key Parameters
• 5.3. Methodology
• 5.4. Company Competitiveness Analysis: Blockchain Technology Providers based in North America (Peer Group I)
• 5.5. Company Competitiveness Analysis: Blockchain Technology Providers based in Europe (Peer Group II)
• 5.6. Company Competitiveness Analysis: Blockchain Technology Providers based in Asia Pacific and RoW (Peer Group III)

6. COMPANY PROFILES

• 6.1. Chapter Overview
• 6.2. Alten Calsoft Labs
  • 6.2.1. Company Overview
  • 6.2.2. Financial Information
  • 6.2.3. Application Areas of Proprietary Platform
  • 6.2.4. Recent Developments and Future Outlook
• 6.3. ConsenSys
  • 6.3.1. Company Overview
  • 6.3.2. Application Areas of Proprietary Platform
  • 6.3.3. Recent Developments and Future Outlook
• 6.4. IBM
  • 6.4.1. Company Overview
  • 6.4.2. Financial Information
  • 6.4.3. Application Areas of Proprietary Platform
  • 6.4.4. Recent Development and Future Outlooks
• 6.5. Stratumn
  • 6.5.1. Company Overview
  • 6.5.2. Application Areas of Proprietary Platform
  • 6.5.3. Recent Development and Future Outlook
• 6.6. Infosys
  • 6.6.1. Company Overview
  • 6.6.2. Financial Information
  • 6.6.3. Application Areas of Proprietary Platform
  • 6.6.4. Recent Developments and Future Outlook
• 6.7. Tech Mahindra
  • 6.7.1. Company Overview
  • 6.7.2. Financial Information
  • 6.7.3. Application Areas of Proprietary Platform
  • 6.7.4. Recent Developments and Future Outlook
• 6.8. Humanscape
  • 6.8.1. Company Overview
  • 6.8.2. Application Areas of Proprietary Platform
  • 6.8.3. Recent Developments and Future Outlook
• 6.9. Hyperledger Foundation
  • 6.9.1. Company Overview
  • 6.9.2. Application Areas of Proprietary Platform
  • 6.9.3. Recent Developments and Future Outlook
• 6.10. Innoplexus
  • 6.10.1. Company Overview
  • 6.10.2. Application Areas of Proprietary Platform
  • 6.10.3. Recent Developments and Future Outlook
• 6.11. Medsphere
  • 6.11.1. Company Overview
  • 6.11.2. Application Areas of Proprietary Platform
  • 6.11.3. Recent Developments and Future Outlook
• 6.12. Solulab
  • 6.12.1. Company Overview
  • 6.12.2. Application Areas of Proprietary Platform
  • 6.12.3. Recent Developments and Future Outlook

7. PARTNERSHIPS AND COLLABORATIONS

• 7.1. Chapter Overview
• 7.2. Partnership Models
• 7.3. Blockchain in Drug Discovery and Clinical Trials: Recent Partnerships and Collaborations
  • 7.3.1. Analysis by Year of Partnership
  • 7.3.2. Analysis by Type of Partnership
  • 7.3.3. Analysis by Year and Type of Partnership
  • 7.3.4. Analysis by Company Size and Type of Partnership
  • 7.3.5. Most Active Players: Distribution by Number of Partnerships
  • 7.3.6. Most Active Players: Distribution by Type of Partnership
  • 7.3.7. Analysis by Type of Pharmaceutical Applications
  • 7.3.8. Analysis by Type of Partner
  • 7.3.9. Analysis by Geographical Region
    • 7.3.9.1. Local and International Agreements
    • 7.3.9.2. Intercontinental and Intracontinental Agreements

8. PUBLICATION ANALYSIS

• 8.1. Chapter Overview
• 8.2. Scope and Methodology
• 8.3. Blockchain Technology in Pharmaceutical Industry: Recent Publications
  • 8.3.1. Analysis by Year of Publication
  • 8.3.2. Analysis by Type of Article
  • 8.3.3. Popular Journals: Analysis by Number of Publications
  • 8.3.4. Popular Publishers: Analysis by Number of Publications
  • 8.3.5. Popular Copyright Holders: Analysis by Number of Publications
  • 8.3.6. Analysis by Popular Keywords
  • 8.3.7. Analysis by Impact Factor
  • 8.3.8. Popular Journals: Analysis by Journal Impact Factor

9. SWOT ANALYSIS

• 9.1. Chapter Overview
• 9.2. Blockchain in Drug Discovery and Clinical Trials: SWOT Analysis
• 9.3. Comparison of SWOT Factors
  • 9.3.1. Strengths
    • 9.3.1.1. Transparency and Traceability
    • 9.3.1.2. Cost Reduction and Data Integrity
    • 9.3.1.3. Safe and Secure Transactions
    • 9.3.1.4. Patient Data Management
  • 9.3.2. Weaknesses
    • 9.3.2.1. Implementation Expense
    • 9.3.2.2. Storage
    • 9.3.2.3. Immutability of Data
    • 9.3.2.4. High Energy Consumption
  • 9.3.3. Threats
    • 9.3.3.1. Blockchain is Prone to Cyber Attacks
    • 9.3.3.2. Scalability
    • 9.3.3.3. Lack of Regulations Issued by Legal Authorities
  • 9.3.4. Opportunities

10. CASE STUDY: APPLICATIONS OF BLOCKCHAIN IN HEALTHCARE AND OTHER INDUSTRIES

• 10.1. Chapter Overview
• 10.2. Applications of Blockchain Across Various Industries
  • 10.2.1. Blockchain in Healthcare
  • 10.2.2. Blockchain in Banking and Financial Industry
  • 10.2.3. Blockchain in Automotive Industry
  • 10.2.4. Blockchain in Education
  • 10.2.5. Blockchain in Telecom Industry
  • 10.2.6. Blockchain in Transportation
  • 10.2.7. Blockchain in Travel Industry

11. MARKET FORECAST AND OPPORTUNITY ANALYSIS

• 11.1. Chapter Overview
• 11.2. Key Assumptions and Methodology
• 11.3. Blockchain in Drug Discovery and Clinical Trials Market, Till 2035
• 11.4. Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of Blockchain
  • 11.4.1. Blockchain in Drug Discovery and Clinical Trials Market for Public Blockchain, Till 2035
  • 11.4.2. Blockchain in Drug Discovery and Clinical Trials Market for Private Blockchain, Till 2035
  • 11.4.3. Blockchain in Drug Discovery and Clinical Trials Market for Hybrid Blockchain, Till 2035
  • 11.4.4. Blockchain in Drug Discovery and Clinical Trials Market for Other Blockchains, Till 2035
• 11.5. Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Type of End-User
  • 11.5.1. Blockchain in Drug Discovery and Clinical Trials Market for Hospitals, Till 2035
  • 11.5.2. Blockchain in Drug Discovery and Clinical Trials Market for Pharmaceutical Industry, Till 2035
  • 11.5.3. Blockchain in Drug Discovery and Clinical Trials Market for Research Institutes, Till 2035
  • 11.5.4. Blockchain in Drug Discovery and Clinical Trials Market for Academic Institutes, Till 2035
• 11.6. Blockchain in Drug Discovery and Clinical Trials Market: Distribution by Key Geographical Regions
  • 11.6.1. Blockchain in Drug Discovery and Clinical Trials Market in North America, Till 2035
  • 11.6.2. Blockchain in Drug Discovery and Clinical Trials Market in Europe, Till 2035
  • 11.6.3. Blockchain in Drug Discovery and Clinical Trials Market in Asia-Pacific, Till 2035
  • 11.6.4. Blockchain in Drug Discovery and Clinical Trials Market in Rest of the World, Till 2035

12. CONCLUDING REMARKS

13. EXECUTIVE INSIGHTS

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS